These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11720474)

  • 21. Cell type-specific methylation of an intronic CpG island controls expression of the MCJ gene.
    Strathdee G; Davies BR; Vass JK; Siddiqui N; Brown R
    Carcinogenesis; 2004 May; 25(5):693-701. PubMed ID: 14729589
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human kallikrein 8 (hK8/TADG-14) expression is associated with an early clinical stage and favorable prognosis in ovarian cancer.
    Shigemasa K; Tian X; Gu L; Tanimoto H; Underwood LJ; O'Brien TJ; Ohama K
    Oncol Rep; 2004 Jun; 11(6):1153-9. PubMed ID: 15138549
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
    Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
    Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Global analysis of chromosome X gene expression in primary cultures of normal ovarian surface epithelial cells and epithelial ovarian cancer cell lines.
    Benoît MH; Hudson TJ; Maire G; Squire JA; Arcand SL; Provencher D; Mes-Masson AM; Tonin PN
    Int J Oncol; 2007 Jan; 30(1):5-17. PubMed ID: 17143508
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Down-regulation and promoter methylation of tissue inhibitor of metalloproteinase 3 in choriocarcinoma.
    Feng H; Cheung AN; Xue WC; Wang Y; Wang X; Fu S; Wang Q; Ngan HY; Tsao SW
    Gynecol Oncol; 2004 Aug; 94(2):375-82. PubMed ID: 15297175
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differentially androgen-modulated genes in ovarian epithelial cells from BRCA mutation carriers and control patients predict ovarian cancer survival and disease progression.
    Motamed-Khorasani A; Jurisica I; Letarte M; Shaw PA; Parkes RK; Zhang X; Evangelou A; Rosen B; Murphy KJ; Brown TJ
    Oncogene; 2007 Jan; 26(2):198-214. PubMed ID: 16832351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of the tumor suppressor gene ARHI in epithelial ovarian cancer is associated with increased expression of p21WAF1/CIP1 and prolonged progression-free survival.
    Rosen DG; Wang L; Jain AN; Lu KH; Luo RZ; Yu Y; Liu J; Bast RC
    Clin Cancer Res; 2004 Oct; 10(19):6559-66. PubMed ID: 15475444
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Caveolin-1 is down-regulated in human ovarian carcinoma and acts as a candidate tumor suppressor gene.
    Wiechen K; Diatchenko L; Agoulnik A; Scharff KM; Schober H; Arlt K; Zhumabayeva B; Siebert PD; Dietel M; Schäfer R; Sers C
    Am J Pathol; 2001 Nov; 159(5):1635-43. PubMed ID: 11696424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inflammation-associated gene expression is altered between normal human ovarian surface epithelial cells and cell lines derived from ovarian adenocarcinomas.
    Gubbay O; Guo W; Rae MT; Niven D; Langdon SP; Hillier SG
    Br J Cancer; 2005 May; 92(10):1927-33. PubMed ID: 15870720
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differences in expression patterns of the tight junction proteins,claudin 1, 3, 4 and 5, in human ovarian surface epithelium as compared to epithelia in inclusion cysts and epithelial ovarian tumours.
    Zhu Y; Brännström M; Janson PO; Sundfeldt K
    Int J Cancer; 2006 Apr; 118(8):1884-91. PubMed ID: 16287068
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intron 9 retention in gene transcripts suggests involvement of CD44 in the tumorigenesis of ovarian cancer.
    Stickeler E; Möbus VJ; Kieback DG; Kohlberger P; Runnebaum IB; Kreienberg R
    Anticancer Res; 1997; 17(6D):4395-8. PubMed ID: 9494539
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression analysis of genes involved in epigenetic regulation and apoptosis in human malignant haematopoietic cell lines treated with 5-azacytidine.
    Stankov K; Bogdanovic G; Kojic V; Stankov S; Jojic N; Popovic L; Popovic S
    J BUON; 2011; 16(1):116-22. PubMed ID: 21674861
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced expression of chemokine (C-C motif) ligand-2 (CCL2) in ovarian adenocarcinoma.
    Arnold JM; Huggard PR; Cummings M; Ramm GA; Chenevix-Trench G
    Br J Cancer; 2005 Jun; 92(11):2024-31. PubMed ID: 15900302
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decreased expression of retinol-binding proteins is associated with malignant transformation of the ovarian surface epithelium.
    Roberts D; Williams SJ; Cvetkovic D; Weinstein JK; Godwin AK; Johnson SW; Hamilton TC
    DNA Cell Biol; 2002 Jan; 21(1):11-9. PubMed ID: 11879576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selenium binding protein 1 in ovarian cancer.
    Huang KC; Park DC; Ng SK; Lee JY; Ni X; Ng WC; Bandera CA; Welch WR; Berkowitz RS; Mok SC; Ng SW
    Int J Cancer; 2006 May; 118(10):2433-40. PubMed ID: 16380993
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Altered expression of the septin gene, SEPT9, in ovarian neoplasia.
    Burrows JF; Chanduloy S; McIlhatton MA; Nagar H; Yeates K; Donaghy P; Price J; Godwin AK; Johnston PG; Russell SE
    J Pathol; 2003 Dec; 201(4):581-8. PubMed ID: 14648661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro down regulation of ICAM-1 and E-cadherin and in vivo reduction of lung metastases of TS/A adenocarcinoma by a lysozyme derivative.
    Pacor S; Gagliardi R; Di Daniel E; Vadori M; Sava G
    Int J Mol Med; 1999 Oct; 4(4):369-75. PubMed ID: 10493977
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipophagy-ICAM-1 pathway associated with fatty acid and oxygen deficiencies is involved in poor prognoses of ovarian clear cell carcinoma.
    Koizume S; Takahashi T; Nakamura Y; Yoshihara M; Ota Y; Sato S; Tadokoro H; Yokose T; Kato H; Miyagi E; Miyagi Y
    Br J Cancer; 2022 Aug; 127(3):462-473. PubMed ID: 35449452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Establishment and growth regulation of a novel ovarian cancer cell line from a poorly-differentiated adenocarcinoma: proposal for a new treatment.
    Mancini A; Borrelli A; Formisano S; Masucci MT; Maffeo A; Perla G; De Martino L; Bevilacqua N; Botti G; Maggino T
    Eur J Gynaecol Oncol; 1999; 20(1):45-52. PubMed ID: 10422682
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Demonstration of somatic rearrangements and genomic heterogeneity in human ovarian cancer by DNA fingerprinting.
    Boltz EM; Harnett P; Leary J; Houghton R; Kefford RF; Friedlander ML
    Br J Cancer; 1990 Jul; 62(1):23-7. PubMed ID: 2390478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.